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Effect of early glucocorticoid treatment on MR and GR in late homology in the ligand-binding domain. Within this sub-
gestation ovine kidney. family MR and GR have the highest sequence identity,
Background. The ontogeny of the renal mineralocorticoid sharing 94% amino acid identity in the DNA binding(MR) and glucocorticoid (GR) receptors in the ovine fetus,
domain and approximately 57% identity in the ligand-and the effects of early exposure to synthetic or natural gluco-
binding domain [2]. MR mediate aldosterone-inducedcorticoids on the expression of these genes in late gestation
were examined. regulation of sodium ion transport in classical epithelial
Methods. A partial cDNA sequence for the ovine MR was target tissues such as distal tubules of the nephron, distal
cloned and used to generate primers and probes to measure colon, salivary and sweat glands [3]. In addition, MRMR mRNA expression by real-time polymerase chain reaction
also play a role in non-epithelial tissues such as the brain(PCR). GR mRNA was also measured. Kidneys were collected
and heart [4].from ovine fetuses at various stages of gestation (days 60 to
140), twin ovine fetuses at 130 days, from ewes treated at days Mineralocorticoid receptors have been reported to
26 to 28 with either saline, dexamethasone or cortisol, and have two distinct physiological ligands depending on the
adult sheep. Ligand binding was used to determine both GR
type of cell and tissue in which they are expressed [1–4].and MR protein levels in all 130-day-old fetuses and adults.
Furthermore, MR have comparably high affinity for bothResults. No significant changes in the expression of either
renal MR or GR were detected throughout gestation. Cytosolic aldosterone and physiological glucocorticoids such as cor-
protein levels were higher in the fetal kidneys than in the adult. tisol in humans and corticosterone in rats [1–4]. Circulat-
There was a significant increase in both fetal MR and GR ing concentrations of glucocorticoids are approximately
mRNA expression, but not protein levels in kidneys from ewes
100 to 1000 times higher than those of aldosterone. Thepretreated with dexamethasone.
principal factor conferring aldosterone selectivity on MRConclusions. MR and GR mRNA are expressed throughout
development in ovine fetal kidneys. Dexamethasone treatment in epithelial tissues is the enzyme 11-hydroxysteroid
resulted in increased expression of MR and GR mRNA but dehydrogenase 2 (11-HSD2), which converts cortisol/
not protein levels. The dissociation between fetal mRNA and corticosterone into the inactive compounds cortisoneprotein levels, relative to adult kidneys, suggests that it may
and 11-dehydrocorticosterone, respectively [5]. Addi-be confounding to draw conclusions based on mRNA levels
tional mechanisms for aldosterone selectivity may in-alone.
clude a longer half-life of MR–aldosterone complexes
than MR–cortisol complexes, possible differences in ef-
ficiency of transactivation of the MR-ligand complex,Mineralocorticoid (MR) and glucocorticoid (GR) re-
and the reported differential propensity to form receptorceptors are members of the steroid/thyroid/retinoic acid
receptor (STR) family [1]. Together with the androgen hetero-/homodimers [6].
(AR), estrogen (ER), and progesterone receptors (PR) Whether renal MR need to be present throughout
they form part of a subfamily sharing over 90% amino development is an open question. The fetus is supplied
acid homology in the DNA binding domain and 50% with water and electrolytes via the placenta [7], the major
organ regulating fluid and electrolyte balance during in-
trauterine life. In mice in which the MR gene is inacti-Key words: cortisol, dexamethasone, glucocorticoid receptor, mineral-
ocorticoid receptor, ontogeny, sheep, development. vated by homologous recombination (MR knockout) the
fetus is born and develops relatively normally with symp-Received for publication May 17, 2001
toms of pseudohypoaldosteronism developing only dur-and in revised form September 4, 2001
Accepted for publication September 19, 2001 ing the first week of life [8]. Studies in which fetal sheep
were bilaterally adrenalectomized in the last third of 2002 by the International Society of Nephrology
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gestation showed no significant effect on urinary sodium/ sheep kidney RNA using the following primer pair: for-
ward primer: GAG AGT CTG GCC GTA ACT TCCpotassium excretion until close to term [9]. Aldosterone,
however, does cross the placenta to some extent [10], and TG, reverse primer: AGT CCA CTG GAG GGG ACA
ACA TAC ATA CAT CGC TCC. The resulting 574 bpthis may have physiological effects on the fetal kidney. A
number of studies have shown that the ovine fetal kidney PCR product was amplified, subcloned into the KS
pBluescript vector and sequenced in an Applied Biosys-can respond to exogenous aldosterone [11–14]. Similarly,
when the MR antagonist spironolactone was infused, tem oligonucleotide Synthesizer (Perkin-Elmer, Nor-
walk, CT, USA).alterations in fetal renal electrolyte excretion were seen,
demonstrating that endogenous aldosterone was ex-
Ontogeny of mineralocorticoid and glucocorticoiderting a physiological effect on the ovine fetal kidney
receptors in ovine kidney[13]. In addition, there are at least two reports of the
occurrence of oligohydramnios in human pregnancies in Pregnant ewes were killed by an overdose of pentobar-
bitone sodium (100 mg/kg body weight; Lethabarb; Ar-which the fetuses were later found to have pseudohypo-
aldosteronism [15, 16]. Thus, in long gestation species nolds, Reading, UK). Tissue samples of kidneys were
collected from non-treated fetuses from each group atthere seems to be a functional MR acting over some part
of gestation. 60 to 65 days (N  7), 100 to 115 days (N  10), and
140 days of gestation (N  4) (term 145 to 150 days).There is substantial epidemiological evidence linking
an unfavorable intrauterine environment, resulting in Saline infused 130-day-old fetuses (N  10) were used
for the ontogeny study. The same group of animals alsolow birth weight for gestational age, with an increased
risk of developing cardiovascular disease (hypertension, was used as the control group in the study of the effect
of glucocorticoid treatment on the MR and GR expres-coronary heart disease) and metabolic disease (type II
diabetes, dyslipidemia) in adult life [17, 18]. In the sheep sion in late gestation ovine kidney. Fresh tissue was fro-
zen in liquid nitrogen to be used for total RNA extrac-model, exposure to excess glucocorticoid for a short pe-
riod (2 days) very early in gestation (26 to 28 days; term tion. In addition kidneys were available from four adult
non-pregnant ewes.145 to 150 days) results in normal birth weight lambs
that develop hypertension due to increased cardiac out-
Effects of early glucocorticoid treatment on the MRput and left ventricular hypertrophy as adults (unpub-
and GR in late gestation ovine kidneylished data) [19]. Similarly, in rat models of intrauterine
programming the kidney has been implicated [20]; in Pregnant Merino ewes carrying twins at 26 to 28 days
of gestation were infused for 48 hours with saline (N preliminary studies GR protein and mRNA were in-
creased in kidneys from fetal and neonatal rats fed a low 10; 5 sets of twins), 0.19 mL/h; cortisol (N  10; 5 sets
of twins, 5 mg/h) or dexamethasone (N  8; 4 sets ofprotein diet, which is known to cause increased blood
pressure in offspring [21]. In the same study no change twins, 0.48 mg/h). Animals were killed at 130 days of
gestation and samples were collected as above.in renal MR gene expression was seen during this period.
Our aim was then twofold: (1) to determine whether
RNA extractionsMR and GR are present and expressed in the ovine fetal
kidney at various stages of gestation; and (2) to study Total RNA was isolated from 0.7 to 1.0 g frozen kidney
tissue as previously described [23]. The kidney samplesthe effect of short-term (48 hours) steroid exposure, at
an early stage of gestation (26 to 28 days of gestation; obtained had both cortex and medulla tissues. Kidney
sections were cut to ensure that each section had equalterm150 days) on the renal expression of MR and GR
later in gestation. distribution of both cortical and medullary tissue. After
DNase treatment, 0.5 g of total RNA was reverse tran-
scribed with appropriate controls to assess for genomic
METHODS
DNA contamination, as previously described [24].
Cloning of the partial ovine MR cDNA
Real-time PCRA sheep genomic library in EMBL3 (Clontech Labo-
ratories Inc., Palo Alto, CA, USA) was screened by Real-time PCR (using an ABI PRISM 7700 Sequence
Detector; Applied Biosystems, Foster City, CA, USA)standard procedures with a 32P-labeled rat MR cDNA.
A clone encoding exon 9 of the sheep MR gene was was used to quantitate gene expression of the MR/GR.
A multiplex comparative CT method was utilized in thisisolated and sequenced. The sequence encoding the ste-
roid binding domain of the receptor was isolated by RT- study, in which the target gene of interest (MR/GR) was
amplified with the endogenous reference 18S, in the samePCR with the 3 primer based on the sequence of exon
9 and the 5 primer designed based on homology between tube. The cycle number at which cDNA amplification
was first detected above background in each well wasthe rat and human MR cDNAs. Reverse transcription-
polymerase chain reaction (RT-PCR) was performed on defined as the CT value. The primers for 18S were limited
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Table 1. Mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) primer and probe sequences,




MR TCCAAAGGATGGCCTCAAAA (465-484) 900
GR ACTGCCCCAAGTGAAAACAGA (402-421) 900
Reverse primer
MR ATCTTTCTCAGCTCCTTGATGTAATTT (513-539) 900
GR AATAAAATGTCTGCCATTTCTGTTCAT (527-552) 900
TaqMan probe
MR TCCTCATTTCTTCAAACGCAGCCTGG (486-511) 100
GR AAAGAAGATTTTATCGAACTCTGCACCCCTG (425-455) 75
For each TaqMan probe, FAM (6-carboxyfluroscein) was attached at the 5 end and TAMRA (6-carboxy-tetraflurescein) at the 3 end. Nucleotide positions are
shown in parenthesis. Accession numbers (GenBank/EMBL) are as follows; mineralococrticoid receptor, AF349768, and glucocorticoid receptor, S44554.
and a validation experiment was performed to ensure 2 mmol/L monothioglycerol, pH 7.4, and homogenized
immediately. The homogenates were centrifuged atthat both test genes (MR/GR) as well as the 18S gene
were amplified at relatively equal efficiencies. 150,000  g for 60 minutes at 4C to yield a cytosol.
Cytosol protein levels were determined by BradfordBoth MR and GR primers and probes were designed
using Primer Express Version 1.0 (Applied Biosys- assay [25] using a Beckman DU530 Life Science UV/
Vis Spectrophotometer (Palo Alto, CA, USA).tems). For GR, a 79 bp fragment was amplified as pre-
viously described [22], and for MR, a 71 bp fragment was For MR binding studies, cytosols (100 L) were incu-
bated in glass tubes for approximately 16 to 18 hours atamplified, using the primers shown in Table 1. Optimal
4C with 100 L of 1 mol/L RU38486 plus doublingconcentrations of the primers and probes are given in
dilutions of [3H]-aldosterone (5 to 0.15 nmol/L) and assayTable 1. The TaqMan probe and primers for 18S were
buffer (100 L), giving a total incubation volume of 300supplied by Applied Biosystems in a control reagent kit.
L. Non-specific binding was determined at each dilutionThe coefficient of variation (CV) for one sample of adult
of [3H] labeled aldosterone by the addition of 1 mol/Lkidney, repeated five times in the one assay, was 24%
(100 L) of the unlabeled aldosterone in place of thefor GR and 33% for MR.
assay buffer.Calculations:
For GR binding studies, cytosols (100 L) were incu-
CT  CT (MR/GR) 	 CT(18S) bated in glass tubes for 16 to 18 hours at 4C with 100
L of 1 mol/L RU28318 plus double dilutions of [3H]CT  CT (MR/GR) 	 CT(calibrator)
dexamethasone (10 to 0.31 nmol/L) and assay buffer (100
Amount of MR/GR relative to the calibrator 2-CT: L), giving a total incubation volume of 300 L. Non-
The calibrator was either the mean of 130-day saline specific binding was determined at each dilution of [3H]
kidneys or four adult kidneys. labeled dexamethasone by the addition of 1 mol/L (100
L) of the unlabeled dexamethasone in place of theLigand binding assay
assay buffer.
[3H]-Aldosterone (60 to 80 Ci/mmol) was obtained from Bound and free steroids were separated by the addi-
New England Corp. (Boston, MA, USA). [3H]-Dexa- tion of 300 L of an ice-cold suspension of hydroxylapa-
methasone (84 Ci/mmol) was obtained from Amersham tite (HAP; 15%, wt/vol) in 50 mmol/L Tris (hydroxy-
(Buckinghamshire, UK); 17 hydroxy-11-4-dimethyla- methyl) aminomethane and 10 mmol/L KH2PO4, pH 7.2.
mino-phenyl-17
-1-propynl-estra-4,9-dien-3-one), a highly After incubation for 20 minutes at 4C with intermittent
specific synthetic glucocorticoid and progesterone antag- mixing, the tubes were centrifuged (1000  g for 5 min),
onist, and RU28318, a mineralocorticoid antagonist (the and the supernatant aspirated. The pellets were washed
potassium salt of 7
-propyl spirolactone) were a gift three times with 1 mL of ice-cold washing buffer (8.5
from Roussel-UCLAF (Paris, France); other unlabeled mmol/L Na2HPO4 · 12H2O, 1.5 mmol/L KH2PO4, 10 mol/L
steroids were supplied from Sigma Chemical Co. (St. Na2MoO4 · 2H2O, pH 7.2). Washed HAP pellets were
Louis, MO, USA). resuspended in 2 mL of ethanol at room temperature
Kidney tissues were removed from 	80C freezer, cut for 15 minutes with intermittent mixing, and centrifuged
into small pieces on a glass petri dish on ice. Samples (1000 g for 5min). The supernatant was added to 4 mL
were then added to an ice-cold assay buffer consisting to Insta-Gel Plus (Packard Bioscience B.V., Amsterdam,
of 8.5 mmol/L Na2HPO4 · 12H2O, 1.5 mmol/L KH2HPO4, the Netherlands) and counted for five minutes on a Pack-
ard Tri-Carb Liquid Scintilation Analyzer 1900CA.10 mmol/L Na2MoO4 · 2H2O, 20% (vol/vol) glycerol,
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Statistics than adult kidney [Bmax  15.7  2.0 fmol/mg in fetal
kidney (N  10) vs. 5.5  2.5 fmol/mg in adult kidneyOne-way analysis of variance (ANOVA) was used
(N  4); P  0.001]. Although prenatal dexamethasoneto compare results for individual samples (Sigma Stat
treatment led to significant up-regulation of MR mRNAPackage; SPSS Inc., Chicago, IL, USA). Results are pre-
in the 130-day ovine kidney the number of binding sitessented as mean  SEM. The Mann-Whitney rank sum
was similar to that found in the control group of animalstest was used for the analysis of results where data were
with prenatal cortisol treatment affecting neither affinitynot normally distributed (results are shown as 25% and
nor the number of binding sites (Fig. 5).75% distribution; Sigma Stat Package, SPSS Inc.).
The affinity of [3H]-dexamethasone binding to the GR
was similar between fetal and adult ovine kidney [Kd
RESULTS 2.0  0.1 nmol/L in fetal kidney (N  10) vs. 1.5  0.2
nmol/L in the adult kidney (N  4); Fig. 4]. Also similarCloning of the partial ovine MR cDNA
to that found for the MR, the number of GR bindingA partial sequence for the ovine MR was obtained
sites was significantly higher in fetal than in the adultusing a combination of genomic library screening and
kidney (Bmax  245  17 fmol/mg fetal kidney (N  10)PCR as described in the Methods section. The sequence
vs. 45  10 fmol/mg adult kidney (N  4); P  0.001].encodes the last 258 amino acids of the ovine MR and
Although prenatal dexamethasone treatment led to sig-includes the steroid-binding domain. This partial MR
nificant up-regulation of GR mRNA in the 130-day ovinecDNA was found to be 93% homologous to human, 97%
kidney, the number of binding sites was similar to thatto rat, 91% to pig (sequence incomplete) and 93% to
found in the control group of animals. Prenatal cortisolmonkey MR cDNA (Fig. 1).
treatment did not affect either parameter (Fig. 5).
Ontogeny of the mRNA for MR and GR in ovine
kidney using real-time PCR DISCUSSION
As shown in Figure 2, both MR and GR mRNA were Cloning of a partial sequence of the ovine MR
detected in ovine fetal kidney at various stages of gesta- The present study reports the partial cloning and ex-
tion, from 60 to 140 days. Results are given relative to pression of the ovine MR, combined with studies on the
the adult kidney. The level of both MR and GR mRNAs expression of the ovine GR in fetal kidneys. The MR
remained constant over the gestation period. has been cloned in a number of species, as shown in
Relative to the adult kidney, the fetal MR mRNA Table 1, and homology in the ligand-binding domain is
expression was between 11% and 30% and fetal GR high amongst different species. Various isoforms of MR
mRNA expression was between 52% and 82% (Fig. 2). have been reported to exist in the rat and the human
[24–26], although we as yet cannot determine if there isEffect of early glucocorticoid treatments on the
more than one MR isoform in the sheep.mRNA for MR and GR in late gestation ovine kidney
There was significant up-regulation of expression of Ontogeny of MR/GR
MR mRNA (P  0.001) and GR mRNA (P  0.05) in The ontogeny study revealed that both MR and GR
130-day kidneys of fetuses exposed to the dexametha- mRNA were present in the ovine fetus from at least 60
sone treatment (N 8) compared to saline controls (N days of gestation and that expression levels remained
10) (Fig. 3). Prenatal cortisol treatment did not affect constant throughout gestation (60 to 140 days). These
either MR or GR gene expression. levels of MR mRNA were lower than those in the four
adults (11 to 30%), in contrast to findings in rats, in
Ligand binding assays which MR mRNA was reported to be three to four times
Ligand binding assays were performed on kidneys higher in the neonate (when kidney is still developing)
from animals at 130 days of gestation treated at 26 to than in the adult [27]. GR mRNA fetal concentrations
28 days of gestation with saline (N 10), dexamethasone also were lower than in adult sheep, whereas in the rat
(N  7) or cortisol (N  10). The same assays were GR mRNA abundance was highest in fetal and neonatal
performed on four adult kidneys to compare the affinity kidneys [28]. There are significant differences in renal
and the number of binding sites in 130-day fetal kidney development in the sheep and the rat; in the sheep the full
versus adult kidney for both MR and GR. complement of nephrons is present about three weeks
As shown in Figure 4, the affinity of [3H]-aldosterone before birth, as in the human, whereas in the rat, most
binding to the MR was similar between fetal and adult renal development occurs in the first seven to ten days
kidney [Kd  4.2  0.7 nmol/L in fetal kidney (N  10) after birth [29]. In the human, MR mRNA is present
vs. 1.9  0.5 nmol/L in adult kidney (N  4)]. The from six weeks of gestation [30] although no quantitative
comparison with adult levels has been made.number of binding sites was significantly higher in fetal
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Fig. 1. Predicted amino acid sequence of the C-terminal end of the ovine mineralocorticoid receptor and multiple sequence alignment with the
deduced amino acid sequences from monkey (T. belangery) (AAF63382), rat (P22199), human (P08235), shrew (Q29131), frog (Q91573) and pig
(P79404; sequence incomplete). Identical and similar amino acids are boxed in black and gray, respectively.
In contrast to the mRNA studies, MR and GR protein, and GR proteins in the adult sheep kidney were similar
in both studies.as determined by ligand binding, gave different results.
The concentration of GR protein (Bmax) was approxi-
Discrepancy between mRNA and protein resultsmately five times greater in the late gestation fetal kidney
as in the adult, while that for MR was threefold higher Thus, there is an apparent discrepancy between the
mRNA results and the ligand binding studies for bothin the fetus. The Kd of the fetal and adult GR and MR
were comparable, and of the same order as that deter- receptors. There are several possible explanations for
this study result. The receptor protein concentration ismined by other workers [31]. The concentrations of MR
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Fig. 3. Effects of early treatments [saline (S), dexamethasone (D) or
cortisol (F)] on the mRNA for (A) MR and GR (B) in late gestation
ovine kidney. All treatments were administered for 48 hours between
26 and 28 days of gestation. The 130-day saline ovine fetal kidney was
used as a calibrator. The results for MR are shown as mean  SEM.
The results for GR expressed as median, 25% and 75% distribution.
***P  0.001.
Fig. 2. Ontogeny of the mRNA for mineralocorticoid (MR; A) and
glucocorticoid (GR; B) receptors in ovine kidney from 60 to 140 days
of gestation. An adult kidney was used as a calibrator. The results are
expressed as median, with filled circles representing 25% and 75% with gestational age in the hypothalamus, anterior pitu-distribution.
itary and adrenal glands of ovine fetuses [36]. Arginine
vasopressin (AVP) mRNA was lower, but pituitary AVP
peptide content was higher, in preterm fetuses than in
expressed per mg of cell protein, and total protein con- the mothers [37]. Thus, the findings of higher cytosolic
centration of renal cells will differ in the fetus and the receptor protein for MR and GR in the ovine fetus are
adult [32]. Protein synthesis rates are much higher in the
not without precedent. The lack of correlation between
fetus than in the adult [32], but turnover of receptor
changes in mRNA expression with early prenatal gluco-protein may be much slower. It is known that phosphory-
corticoid treatment and the lack of apparent change inlation of the murine GR protein has a profound effect
cytosolic protein is unexpected. This finding suggests thatupon its stability [33]; if GR and MR are largely non-
it may be confounding to draw conclusions based onphosphorylated in the fetal kidney, then the half-lives
mRNA levels alone.of these proteins may be prolonged. In terms of the GR
protein, Western blots with polyclonal antibodies to the Evidence for the functionality of the MR in the fetus
human GR protein, on ovine fetal hypothalamus and
Mineralocorticoid receptor and GR present at the pro-pituitaries, detected two different sized proteins: one
tein level in this study are functional. Numerous studiesnormal, and one approximately half-size [34]. The pro-
have shown physiological effects of glucocorticoids inportion of the half-length receptor was greater in three-
developing metanephric kidneys. In the immature meta-to four-week-old lambs than in fetuses, suggesting possi-
nephros cortisol causes diuresis and natriuresis [38]. Al-ble differences in receptor turnover, at least in some
dosterone, on the other hand, causes sodium retentiontissues.
and kaliuresis [11–14]. It is generally agreed that theEven with quantitative mRNA data, such as provided
effect of aldosterone in the fetal kidney is less than thatby real-time PCR, one cannot necessarily expect good
of the adult kidney, but this could be due, in large part,correlations between mRNA and protein for low abun-
to the greater sodium load delivered to the distal tubuledance transcripts [35]. The number of GR, but not the
amount of measured GR mRNA changed significantly of the immature kidney. In the adult, at least 80% of the
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Fig. 4. Affinity (Kd; A) and the concentration (Bmax; B) of MR and GR
in late gestation ovine kidney compared to the adult kidney. The results Fig. 5. Effects of early treatments [saline (S), dexamethasone (D) or
are shown as mean  SEM. ***P  0.001. cortisol (F)] on the affinity (Kd; A) and the concentration (Bmax; B)
of MR and GR in late gestation ovine kidney. All treatments were
administered for 48 hours between 26 and 28 days of gestation. The
results are shown as mean  SEM.
filtered sodium is reabsorbed in the proximal convoluted
tubule and pars recta, with remainder largely reabsorbed
distal to this point. In the fetal kidney the total fractional Programming effects of dexamethasone versus cortisol
reabsorption of sodium is lower, at 96.5% (rather than Exposure of the ovine fetus to dexamethasone, at a
99%) and only 65% is reabsorbed in the proximal time at which the only functioning kidney is a mesoneph-
segment [38, 39]. Therefore, even under the influence ros [22], caused a significant increase in mRNAs for both
of very high concentrations of plasma aldosterone the MR and GR, whereas the exposure to maximal cortisol
fractional excretion of sodium is greater in the fetal kid- levels did not. This may have been due to dexamethasone
ney (1.9%) than in the normal adult kidney (1.0%) accessing the fetal compartment more efficiently than
[14]. If some of fetal kidney GR mRNA encodes a GR cortisol, or the dexamethasone exerting this ‘program-
receptor (as yet unknown in sheep), and this dimerizes ming’ effect via a different receptor, such as the pregnane
with the MR, this also may reduce the physiological X receptor (PXR), which ‘sees’ dexamethasone but not
cortisol [41]. No studies have shown the presence ofeffectiveness of aldosterone [40].
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25), in Principles of Perinatal-Neonatal Metabolism (2nd ed), editedsuch a receptor in the tissues of the ovine fetus early in
by Cowett RM, Springer, 1998, pp 511–536
gestation. However, it is quite remarkable that treatment 8. Berger S, Bleich M, Schmid W, et al: Mineralocorticoid receptor
knockout mice: Pathophysiology of Na metabolism. Proc Natlof a fetus, at a stage when the permanent metanephric
Acad Sci USA 5:9424–9429, 1998kidney is represented by only some metanephrogenic
9. Benson CA, Wintour EM: The effect of bilateral fetal adrenalec-
mesenchyme and the first branching of the ureteric bud, tomy on fluid balance in the ovine fetus. J Physiol 489:235–241,
1995can affect gene expression in the developed kidney some
10. Wintour EM, Coghlan JP, Hardy KJ, et al: Placental transfer ofone hundred days later.
aldosterone in the sheep. J Endocrinol 86:305–310, 1980
11. Lingwood B, Hardy KJ, Coghlan JP, et al: Effect of aldosterone
on urine composition in the chronically cannulated ovine fetus.
CONCLUSION J Endocrinol 76:553–554, 1978
12. Robillard JE, Nakamura KT, Lawton WJ, et al: Effects of aldo-In cloning the partial sequence of the ovine MR, to sterone on urinary kallikrein and sodium excretion during foetal
our knowledge for the first time we were able to monitor life. Pediatr Res 19:1048–1052, 1985
13. Kairaitis K, Lumbers ER: The influence of endogenous mineralo-changes in MR mRNA and protein in the ovine fetus.
corticoids on the composition of foetal of fetal urine. J Dev Physiol
The level of both MR and GR mRNA remains relatively 13:347–351, 1990
14. Mann SE, Nijland MJM, Ross MG: Fetal absorption of intra-constant throughout gestation. The synthetic glucocorti-
amniotic aldosterone: Effects on urine composition. J Soc Gynecolcoid, dexamethasone, increased levels of both MR and
Investig 6:252–257, 1999
GR mRNA administered short term in early gestation, 15. Greenberg D, Abramson O, Phillip M: Fetal pseudohypoaldoste-
ronism: Another cause of hydramnios. Acta Paediatr 84:582–584,whereas the natural glucocorticoid cortisol had no effect
1995on MR or GR gene expression. Thus, up-regulation of
16. Narchi H, Santos M, Kulaylat N: Polyhydramnios as a sign of
gene expression for both MR and GR is evidence for a fetal pseudohypoaldosteronism. Int J Gynaecol Obstet 69:53–54,
2000programming effect occurring in utero.
17. Osmond C, Barker DJP: Fetal, infant, and childhood growth areThe dissociation between fetal mRNA and protein predictors of coronary heart disease, diabetes and hypertension in
levels, relative to adult kidneys, suggests that it may be adult men and women. Environ Health Perspect 108:545–553, 2000
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